Avalo Therapeutics Inc (AVTX) — Free Cash Flow Generation Index
Avalo Therapeutics Inc (AVTX) has a Free Cash Flow Generation Index of 0.99x as of September 2022. Free cash flow of $5.69 Million represents 1% of operating cash flow ($5.73 Million). Read how much debt does Avalo Therapeutics Inc carry for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Avalo Therapeutics Inc Free Cash Flow Generation Index (2017–2017)
Historical FCF Generation Index trend for Avalo Therapeutics Inc across 1 annual periods. Explore Avalo Therapeutics Inc (AVTX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Avalo Therapeutics Inc (2017–2017)
Year-by-year Free Cash Flow Generation Index for Avalo Therapeutics Inc. For the full company profile including market capitalisation, see Avalo Therapeutics Inc market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2017 | 1.00x | $12.50 Million | $12.52 Million | $23.32K | — |